HARVARD BIOSCIENCE, INC. (HBIO) Revenue 2016–2025
HARVARD BIOSCIENCE, INC. (HBIO) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$86.5MFY2025 · since FY2016: $104.5M → $86.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $86.5M | -8.1% |
| FY2024 | $94.1M | -16.1% |
| FY2023 | $112.3M | -1.0% |
| FY2022 | $113.3M | -4.7% |
| FY2021 | $118.9M | +16.5% |
| FY2020 | $102.1M | -12.1% |
| FY2019 | $116.2M | -3.8% |
| FY2018 | $120.8M | +56.0% |
| FY2017 | $77.4M | -25.9% |
| FY2016 | $104.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More HBIO financial trends
HBIO Net incomeHBIO Net marginHBIO Gross profitHBIO Gross marginHBIO Operating incomeHBIO Operating marginHBIO Operating cash flowHBIO Free cash flowHBIO Capital expendituresHBIO Return on equityHBIO Stock buybacksHBIO Dividends paidHBIO Total assetsHBIO Total liabilitiesHBIO Shareholders’ equityHBIO overview →